Compounds that bind bacterial pili

Details Compounds that bind bacterial pili Compounds that bind bacterial pili

1996-12-06

1999-12-07

Peselev, Elli

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 41, 536 172, 536 179, 514 23, A61K 3170, C07H 1500, C07H 1700

Patent

active

059983817

ABSTRACT:
Diagnostics and treatments for bacterial infection are disclosed. The treatments prevent bacteria from adhering to host cells by interfering with the binding of the bacteria to cell receptors. Compounds that inhibit bacterial adherence to cells are engineered to be readily modified for best efficacy with different modes of treatment. The compounds can be readily modified for use to identify bacteria according to their cell binding specificities.

REFERENCES:
patent: 4536572 (1985-08-01), Kim et al.
patent: 4867973 (1989-09-01), Goers et al.
patent: 5198352 (1993-03-01), Neeser et al.
N. Sharon, "Bacterial Lectins, Cell-Cell Recognition and Infectious Disease," FEBS Letters 217: 145-157 (1987).
H.-G. Leusch et al., "Binding of Escherichia Coli and Salmonella Strains to Members of the Carcinoembryonic Antigen Family: Differential Binding Inhibition by Aromatic .alpha.-Glycosides of Mannose," Infection and Immunity 59: 2051-2057 (1991).
B. Madison et al., "Type 1 Fimbrial Shafts of Escherichia Coli and Klebsiella Pneumoniae Influence Sugar-Binding Speificities of Their FimH Adhesins," Infection and Immunity 62:843-848 (1994).
N. Firon et al., "Aromatic Alpha-Glycosides of Mannose Are Powerful Inhibitors of the Adherence of Type 1 Fimbriated Escherichia Coli to Yeast and Intestinal Epithelial Cells," Infection and Immunity 55(2):472-476 (1987).
K.A. Schulman et al., "Cost-Effectiveness of HA-1A Monoclonal Antibody for Gram-Negative Sepsis: Economic Assessment of a New Therapeutic Agent," JAMA 266:3466-3471 (1991).
C.J. Fisher et al., "Initial Evaluation of Human Monoclonal Anti-Lipid A Antibody (HA-1A) in Patients with Sepsis Syndrome," Clin. Care Med., 18:1311-1315 (1990).
C.H.J. Ford et al., "Antibody Mediated Targeting of Radioisotopes, Drugs and Toxins in Diagnosis and Treatment," Indian J. Pediatr., 57:29-46 (1990).
H.F. Deutsch, "Preparation of Immunoglobulin Concentrates," in Methods in Immunology and Immunochemistry, (C.A. Williams and M.W. Chase, eds.), Academic Press, New York, pp. 315-321 (1967).
E.J. Cohn et al., "Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation in Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids," J. Am. Chem Soc., 68:459-475 (1946).
G.L. Mandell and M.A. Sande, "Antimicrobial Agents: Pencillins, Cephalosporins, and Ohter Beta-Lactam Antibiotics," in Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 8th Ed., (Gilman, Rall, Nies, and Taylor, eds.), Pergamon Press, New York, 46:1065-1097 (1990).
M.A. Sande and G.L. Mandell, "Antimicrobial Agents: Tetracyclines, Chloramphenicol, Erthromycin, and Miscellaneous Antibacterial Agents," in Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 8th Ed., (Gilman, Rall, Nies, and Taylor, eds.), Pergamon Press, New York, 48:1117-1145 (1990).
A. Fiechter, "Biosurfactants: Moving Towards Industrial Application," Trends in Biotech., 10:208-217 (1992).
G.L. Mandell and M.A. Sande, "Antimicrobial Agents: Drugs Used in the Chemotherapy of Tuberculosis and Leprosy," in Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 8th Ed., (Gilman, Rall, Nies, and Taylor, eds.), Pergamon Press, New York, 49:1146-1164 (1990).
R.G. Douglas, "Antimicrobial Agents: Antiviral Agents," in Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 8th Ed., (Gilman, Rall, Nies, and Taylor, eds.), Pergamon Press, New York, 51:1182-1201 (1990).
J.E. Bennett, "Antimicrobial Agents; Antifungal Agents," in Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 8th Ed., (Gilman, Rall, Nies, and Taylor, eds.), Pergamon Press, New York, 50:1165-1181 (1990).
T. Nakamura et al., "Tachyplesin, a Class of Antimicrobial Peptide from the Hemocytes of the Horseshoe Crab (Tachypleus tridentatus): Isolation and Chemical Structure," J. Biol. Chem., 263:16709-16713 (1988).
G. Alpert et al, "Limulus Antilipopolysaccharide Factor Protects Rabbits from Meningococcal Endotoxin Shock," Journal of Infectious Diseases 165:494-500 (1992).
R.R. Schumann et al., "Structure and Function of Lipopolysaccharide Binding Protein," Science 249:1429-1431 (1990).
M.N. Marra et al., "The Role of Bactericidal/Permeability-Increasing Protein as a Natural Inhibitor of Bacterial Endotoxin," J. Immunol., 148:532-537 (1992).
R. Berkow and A.J. Fletcher (eds), The Merck Manual, 16th ed., p. 46 (1992).
G.F. Brooks et al., Jawetz, Melnick & Adelberg's Medical Microbiology, 19th ed., pp. 172-173, (1991).
Pierce Chemical Co., (Rockford, IL), General Catalog, pp. E-10-E-39 (1992).
I.S. Snyder and R.G. Finch, "Basic Concepts of Chemotherapy," in Modern Pharmacology, 2d Ed., (C.R. Craig and R.E. Stitzel, eds.), Little, Brown and Company, Boston, 45:631-640 (1986).
J.E. Conte, Jr. and S.L. Barriere, "Antibiotic Susceptibilities," Manual of Antibiotics and Infectious Diseases, 6th Ed., Lea and Febiger, Philadelphia, Sec. IV, pp. 135-152 (1988).
L.E. Hood et al., Immunology, 2d Ed., The Benjamin/Cummings Publishing Company, Inc., Menlo Park, pp. 339-340 (1984).
M. Pollack et al., "Enhanced Survival in Pseudomonas aeruginosa Septicemia Associated with High Levels of Circulating Antibody to Escherichia coli Endotoxin Core," J. Clin. Invest., 72:1874-1881 (1983).
S.H. Zinner and W.R. McCabe, "Effects of IgM and IgG Antibody in Patients with Bacteremia Due to Gram-negative Bacilli," J. Infect. Dis., 133:37-45 (1976).
B.J. Stoll et al., "Antibodies to Endotoxin Core Determinants in Normal Subjects and in Immune Globulins for Intravenous Use," Serodiagnosis and Immunotherapy 1:21-31 (1987).
W. Marget et al., "Lipid A Antibody Determinations Using ELISA on Patients at a Children's Hospital: A Preliminary Report," Infection 11:84-86 (1983).
C. Stoll et al., "Serum Antibodies Against Common Antigens of Bacterial Lipopoly-saccharides in Healthy Adults and in Patients with Multiple Myeloma," Infection 13;115-119 (1985).
M. Sela, "Immunological Studies with Synthetic Polypeptides," in Advances in Immunology, vol. 5, (F. Dixon and J. Humphrey, eds.), pp. 29-129 (1966).
R.C. Bone, "The Pathogenesis of Sepsis," Ann. Intern. Med., 115:457-469 (1991).
E.S. Caplan and N. Hoyt, "Infection Surveillance and Control in the Severely Traumatized Patient," Am. J. Med., 70:638-640 (1981).
M. Meek et al., "The Baltimore Sepsis Scale: Measurement of Sepsis in Patients with Burns Using a New Scoring System," J. Burn Care Rehab., 12:564-568 (1991).
T.J. Zuerlein et al., "Superficial Cultures in Neonatal Sepsis Evaluations: Impact on Antibiotic Decision Making," Clin. Ped., 29:445-447 (1990).
R.L. Nichols, "Classification of Surgical Wounds and nonoperative Factors Influencing Surgical Wound Infection," in Decision Making in Surgical Sepsis, B.C. Decker, Inc., Philadelphia, pp. 20-21 (1991).
R.L. Greenman et al., "A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis," JAMA 266:1087-1102 (1991).
M.A. Awad et al., "Plasma Endotoxin and Glycolipid Antibodies in Children with Meningitis," Acta Paediatri., 81:560-561(1992).
W.K. Joklik et al. (eds), Zinsser Microbiology, 18th ed., p. 485, Appleton-Century-Crofts, Norwalk, CT (1984).
J.M. Slack and I.S. Snyder, Bacteria and Human Disease, pp. 128-133, Yearbook Medical Publishers (1978).
P.Y. Paterson, "Central Nervous System Infection: General Considerations," Biologic and Clinical Basis of Infectious Diseases, 3d ed., (G.P. Youmans et al., eds.), W.B. Saunders Co. pp. 552-568, (1985).
D.D. Morris et al., "Endotoxemia in Neonatal Calves Given Antiserum to a Mutant Escherichia coli (J-5)," Am. J. Vet. Res., 47:2554-2565 (1986).
A.M. Hoffman et al., "Prognostic Variables for Survival of Neonatal Foals Under Intensive Care," J. Vet. Int. Med., 6:89-95 (1992).
K. Hanasawa et al., "New Approach to Endotoxic and Septic Shock by Means of Polymyxin B Immobilized Fiber," Surg. Gyn. & Ob., 168:323-331 (1989).
K. W. Talmadge and C.J. Siebert, "Efficient Endotoxin Removal with a New Sanitizable Affinity Column: Affi-Prep Polymyxin," J. Chrom., 476:175-185 (1989).
T. Kitagawa et al., "Sensitive Enzym

Affiliated with

Also associated with

Rating

Compounds that bind bacterial pili does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds that bind bacterial pili, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds that bind bacterial pili will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-823852